Cost-Effectiveness in Health Care

Featured

One goal of health policy research is to improve cost effectiveness without compromising quality of care. RAND researchers examine treatments, programs, drugs, and technologies in terms of their costs, their cost effectiveness, and the alternatives that may or may not present a better, more efficient way forward.

  • Four adults wearing prosthetics

    Report

    Are Advanced Prosthetics Worth the Costs?

    Sep 5, 2017

    Prosthetic knees and feet allow for more-dynamic movements and improve user quality of life, but payers have recently started questioning their value for money. A simulation model can assess the clinical outcomes and costs of microprocessor-controlled knees compared with more traditional ones.

  • Pharmaceutical bottles and a syringe in a laboratory

    Report

    Biosimilar Drugs May Reduce U.S. Health Spending by $54 Billion

    Oct 23, 2017

    Biologics are complex drugs used to treat rheumatoid arthritis, cancer, and other diseases. They accounted for 70 percent of the growth in U.S. prescription drug spending between 2010 and 2015. Biosimilar versions of biologics could cut health care costs by $54 billion over the next decade.

Explore Cost-Effectiveness in Health Care